Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Non-cash Items (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Non-cash Items for 8 consecutive years, with $9.7 million as the latest value for Q1 2025.

  • On a quarterly basis, Non-cash Items fell 28.68% to $9.7 million in Q1 2025 year-over-year; TTM through Mar 2025 was $9.7 million, a 28.68% decrease, with the full-year FY2024 number at $248617.0, up 11.48% from a year prior.
  • Non-cash Items was $9.7 million for Q1 2025 at Precision Biosciences, up from $248617.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $44.3 million in Q2 2021 to a low of $176113.0 in Q4 2022.
  • A 5-year average of $21.3 million and a median of $20.2 million in 2023 define the central range for Non-cash Items.
  • Biggest YoY gain for Non-cash Items was 59.41% in 2022; the steepest drop was 96.36% in 2022.
  • Precision Biosciences' Non-cash Items stood at $4.8 million in 2021, then crashed by 96.36% to $176113.0 in 2022, then increased by 26.63% to $223019.0 in 2023, then increased by 11.48% to $248617.0 in 2024, then soared by 3801.58% to $9.7 million in 2025.
  • Per Business Quant, the three most recent readings for DTIL's Non-cash Items are $9.7 million (Q1 2025), $248617.0 (Q4 2024), and $16.7 million (Q3 2024).